Haloperidol alone or in combination for acute mania (Q24245158)

PubMed

29 October 2023

3

John Geddes

J R

Geddes

1 reference

PubMed

29 October 2023

Jennifer M Rendell

2

J M

Rendell

1 reference

PubMed

16856043

Cochrane Database of Systematic Reviews

29 October 2023

publication date

19 July 2006

0 references

published in

0 references

cites work

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Haloperidol blood levels in acute mania with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

A double-blind, randomized, prospective evaluation of the efficacy and safety of risperidone versus haloperidol in the treatment of schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Acute high-dose parenteral haloperidol treatment of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Rapid Tranquilization of Acutely Psychotic Patients with Intramuscular Haloperidol and Chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Olanzapine versus haloperidol in schizoaffective disorder, bipolar type

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Are patients with bipolar affective disorder socially disadvantaged? A comparison with a control group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Historical perspectives and natural history of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Suicide as an outcome for mental disorders. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

One hundred years of schizophrenia: a meta-analysis of the outcome literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Neuropsychological functioning of first-episode schizophreniform patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Pharmacologic treatment of schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Schizoaffective disorder: role of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

The epidemiology of DSM-III-R bipolar I disorder in a general population survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Pharmacologic agents for the treatment of acute bipolar mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Olanzapine versus haloperidol treatment in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Health care utilization and costs among patients treated for bipolar disorder in an insured population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Olanzapine versus haloperidol in the treatment of schizoaffective disorder. Acute and long-term therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

Rapid tranquilization: A comparative study of thiothixene and haloperidol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

Pretreatment plasma HVA and haloperidol response in acute mania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

[Differences between unipolar and bipolar affective disorders. Review and results from a clinical population]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

Carbamazepine compared to haloperidol in acute mania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

A controlled Nordic multicentre study of zuclopenthixol acetate in oil solution, haloperidol and zuclopenthixol in the treatment of acute psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

Dosage of haloperidol for mania

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004362.PUB2

7 January 2021

10.1002/14651858.CD004362.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_56reetjuw5hnhbdatyirjkr3sy

0 references